Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance

A legfontosabb adatok

Ki végzi
The University of Hong Kong
Hol
Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Befejeződött
Résztvevők
162 fő vett részt
Kezdés
2021. okt. 4.
Befejezés
2024. aug. 8.
A vizsgálat típusa
Beavatkozással járó, 4 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Cardiac Magnetic Resonance, Blood Tests
A regiszteradat frissítve
2025. május 11.

Ki vehet részt

Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 11 feltétel megnézéseKevesebb

Ki vehet részt

  • Recovered COVID-19 patients; Definition of recovered COVID-19 patient:
  • COVID-19 diagnosis = established by a positive reverse transcription polymerase chain reaction (RT-PCR) for severe acute respiratory syndrome coronavirus-2 [SARS-CoV2] and recovered from COVID-19
  • Recovery = based on two criteria: (1) two negative nasopharyngeal swab RT-PCR results >24 hours apart and (2) absence of fever and improvement in respiratory symptoms; Recovered non-COVID-19 patients with viral respiratory infections confirmed with viral polymerase chain reaction testing AND with a confirmed negative COVID-19 RT-PCR test; Age and gender matched controls with no cardiac risk factors, not on cardiac medications, no history of myocardial infarction, heart failure or myocarditis, negative COVID-19 RT-PCR test and negative COVID-19 antibodies test; Vaccination controls who planning to receive a 2-dose COVID-19 vaccine, with no history of myocardial infarction, heart failure or myocarditis AND with a confirmed negative COVID-19 RT-PCR test

Ki nem vehet részt

  • Previous myocardial infarction or myocarditis unrelated to COVID-19 infection
  • History of heart failure unrelated to COVID-19 infection
  • Presence of pacemakers or implantable cardiac defibrillators
  • Limited life expectancy <1 year, for example due to pulmonary disease, cancer or significant hepatic failure
  • Renal impairment with eGFR <45ml/min/1.73m2
  • Any contraindication for CMR testing
  • Refusal or inability to sign an informed consent
  • Potential for non-compliance towards the requirements in the trial protocol (especially the medical treatment) or follow-up visits

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Introduction:

A teljes eredeti leírásKevesebb

Coronavirus disease 2019 (COVID-19) remains a major health issue resulting in >800,000 deaths as of 30th August 2020. A concerning discovery of COVID-19 is the involvement of the myocardium. Several case studies including one from our group (recent study publication in JACC Cardiovascular Imaging led by the principal investigator of this grant application) have demonstrated subclinical myocardial inflammation in patients using cardiac magnetic resonance imaging (CMR) who have recovered from COVID-19. Furthermore at a cellular level, a recent autopsy study indicated that the severe acute respiratory syndrome coronavirus-2 is present in the myocardial tissue. The study further described invasion and viral progeny occurring in the myocardial interstitial cells and as such is a concerning development with the longer-term implications being unknown. These concerns have been noticed by the cardiology and non-cardiology medical community, with some expressing concerns of a new cause for cardiomyopathy and heart failure secondary to COVID-195. Therefore, it is critical that further studies are conducted to determine the longer-term outcome for patients.

A vizsgálat 4 csoportja

  • Recovered COVID-19 patientsMár használt kezelés, összehasonlításként

    Recovered COVID-19 Patients will undergo three CMR examinations. The scans will take place at (i) within 2 weeks of confirmed recovery, (ii) 3 months after recovery and (iii) 1 year after recovery. At time of CMR examinations, patients will have blood tests.

    Kezelés: Cardiac Magnetic Resonance, Blood Tests

  • non-COVID-19 patients with viral respiratory infectionsA vizsgált kezelés

    non-COVID-19 Patients will undergo three CMR examinations. The scans will take place at (i) within 2 weeks of confirmed recovery, (ii) 3 months after recovery and (iii) 1 year after recovery. At time of CMR examinations, patients will have blood tests.

    Kezelés: Cardiac Magnetic Resonance, Blood Tests

  • Volunteers as age and gender matched controls.A vizsgált kezelés

    Volunteer controls will undergo one CMR examination. At time of CMR examinations, patients will have blood tests.

    Kezelés: Cardiac Magnetic Resonance, Blood Tests

  • Volunteers who planning to receive a 2-dose COVID-19 vaccine as vaccination controlsA vizsgált kezelés

    Vaccination controls will undergo two CMR examinations. The scans will take place (i) within 2 weeks before received 1st dose of COVID-19 vaccine and (ii) within 2 weeks (preferably 5-7 days) after receiving the 2nd dose of COVID-19 vaccine. At time of CMR examinations, patients will have blood tests.

    Kezelés: Cardiac Magnetic Resonance, Blood Tests

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Publikációk
A regiszteradat frissítve
2025. május 11.